Troponin in critically ill patients

Minerva Anestesiologica

Volumn 78, Issue 9, 2012, Pages 1039-1045

  Hamilton, M A ^a   Toner, A ^a   Cecconi, M ^a  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Biological markers; Critical care; Myocardial infarction; Troponin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; TROPONIN;

ACUTE HEART FAILURE; CRITICALLY ILL PATIENT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART INFARCTION; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; INCIDENCE; INTENSIVE CARE; KIDNEY FAILURE; OXYGEN SUPPLY; PROGNOSIS; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; REVIEW; SENSITIVITY ANALYSIS; SEPSIS; STROKE; TRAUMATIC BRAIN INJURY;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CRITICAL ILLNESS; DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE; KIDNEY DISEASES; MYOCARDIAL INFARCTION; MYOCARDIUM; OXYGEN CONSUMPTION; PROGNOSIS; RESPIRATORY INSUFFICIENCY; SENSITIVITY AND SPECIFICITY; SEPSIS; TROPONIN I; TROPONIN T;

EID: 84866354371     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69.
2. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M et al. Universal definition of myocardial infarction. Circulation 2007;116:2634-53.
3. Lim W, Qushmaq I, Devereaux PJ, Heels-Ansdell D, Lauzier F, Ismaila AS et al. Elevated cardiac troponin measurements in critically ill patients. Arch Intern Med 2006;166:2446-54.
4. Lim W, Whitlock R, Khera V, Devereaux PJ, Tkaczyk A, Heels-Ansdell D et al. Etiology of troponin elevation in critically ill patients. J Crit Care 2010;25:322-8.
5. Ammann P, Maggiorini M, Bertel O, Haenseler E, Joller-Jemelka HI, Oechslin E et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003;41:2004-9.
6. Mehta NJ, Khan IA, Gupta V, Jani K, Gowda RM, Smith PR. Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock. Int J Cardiol 2004;95:13-7.
7. Vasile VC, Chai HS, Khambatta S, Afessa B, Jaffe AS. Significance of elevated cardiac troponin T levels in critically ill patients with acute respiratory disease. Am J Med 2010;123:1049-58.
8. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a metaanalysis. Circulation 2005;112:3088-96.
9. Sommerer C, Beimler J, Schwenger V, Heckele N, Katus HA, Giannitsis E et al. Cardiac biomarkers and survival in haemodialysis patients. Eur J Clin Invest 2007;37:350-6
10. Lankeit M, Friesen D, Aschoff J, Dellas C, Hasenfuss G, Katus H et al. Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism. Eur Heart J 2010;31:1836-44
11. Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007;116:1242-9.
12. Peacock WF, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008;358:2117-26.
13. Perna ER, Macin SM, Canella JP, Augier N, Stival JL, Cialzeta JR et al. Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification. Circulation 2004;110:2376-82.
14. Sandhu R, Aronow WS, Rajdev A, Sukhija R, Amin H, D'Aquila K et al. Relation of cardiac troponin I levels with in-hospital mortality in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Am J Cardiol 200 8;102:632-4.
15. van den Bos EJ, Constantinescu AA, van Domburg RT, Akin S, Jordaens LJ, Kofflard MJ. Minor elevations in troponin I are associated with mortality and adverse cardiac events in patients with atrial fibrillation. Eur Heart J 2011;32:611-7.
16. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77.
17. Lim W, Holinski P, Devereaux PJ, Tkaczyk A, McDonald E, Clarke F et al. Detecting myocardial infarction in critical illness using screening troponin measurements and ECG recordings. Crit Care 2008;12:R36.
18. Apple FS. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009;55:1303-6.
19. Leistner DM, Klotsche J, Pieper L, Stalla GK, Lehnert H, Silber S et al. Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary prevention. Clin Chem 2012;58:200-8.
20. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010;304:2503-12.
21. Gilstrap LG, Wang TJ. Biomarkers and cardiovascular risk assessment for primary prevention: an update. Clin Chem 2012;58:72-82.
22. Mills NL, Churchhouse AM, Lee KK, Anand A, Gamble D, Shah AS et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 2011;305:1210-6.
23. White HD, Chew DP. Acute myocardial infarction. Lancet 2008;372:570-84.
24. Apple FS, Collinson PO. Analytical characteristics of high sensitivity cardiac troponin assays. Clin Chem 2012;58:54-61.
25. Gundre P KM, Kulbak G, Kupfer Y, Tessler S. Elevated Troponin Cs in Intensive Care Units A Nationwide Survey of Critical Care Physicians. Chest 2011;140:1013
26. Walsh TS, McClelland DB, Lee RJ, Garrioch M, Maciver CR, McArdle F et al. Prevalence of ischaemic heart disease at admission to intensive care and its influence on red cell transfusion thresholds: multicentre Scottish Study. Br J Anaesth 2005;94:445-52.
27. Terkelsen CJ, Lassen JF, Norgaard BL, Gerdes JC, Jensen T, Gotzsche LB et al. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Eur Heart J 2005;26:18-26.
28. Reynolds T, Cecconi M, Collinson P, Rhodes A, Grounds RM, Hamilton M. Raised serum cardiac troponin I concentrations predict hospital mortality in intensive care unit patients. Br J Anaest 2012;109:219-24.
29. Wilson J JG. Principles and practice of screening for disease. Geneva: WHO; 1968
30. Agewall S, Giannitsis E, Jernberg T, Katus H. Troponin elevation in coronary vs. non-coronary disease. Eur Heart J 2011;32:404-11.
31. Daniels LB, Laughlin GA, Clopton P, Maisel AS, Barrett-Connor E. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. J Am Coll Cardiol 2008;52:450-9.
32. Mingels A, Jacobs L, Michielsen E, Swaanenburg J, Wodzig W, van Dieijen-Visser M. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 2009;55:101-8.
33. Ellison GM, Waring CD, Vicinanza C, Torella D. Physiological cardiac remodelling in response to endurance exercise training: cellular and molecular mechanisms. Heart 2012;98:5-10.
34. Aldous SJ, Richards AM, Cullen L, Than MP. Early dynamic change in high-sensitivity cardiac troponin T in the investigation of acute myocardial infarction. Clin Chem 2011;57:1154-60.
35. Stein R, Gupta B, Agarwal S, Golub J, Bhutani D, Rosman A et al. Prognostic implications of normal (<0.10 ng/ml) and borderline (0.10 to 1.49 ng/ml) troponin elevation levels in critically ill patients without acute coronary syndrome. Am J Cardiol 2008;102:509-12.
36. Rosjo H, Varpula M, Hagve T, Karlsson S, Ruokonen E, Pettila V et al. Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome. Intensive Care Med 2011;37:77-85.
37. Tiruvoipati R, Sultana N, Lewis D. Cardiac troponin I does not independently predict mortality in critically ill patients with severe sepsis. Emergency Medicine Australasia 2012;24:151-8.
38. Redfern G, Rodseth RN, Biccard BM. Outcomes in vascular surgical patients with isolated postoperative troponin leak: a meta-analysis. Anaesthesia 2011;66:604-10.
39. Hickson LJ, Cosio FG, El-Zoghby ZM, Gloor JM, Kremers WK, Stegall MD et al. Survival of patients on the kidney transplant wait list: Relationship to cardiac troponin T. Am J Transplant 2008;8:2352-9.
40. Deegan PB, Lafferty ME, Blumsohn A, Henderson IS, McGregor E. Prognostic value of troponin T in hemodialysis patients is independent of comorbidity. Kidney Int 2001;60:2399-405.
41. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002;106:2941-5.
42. Heresi GA, Tang WH, Aytekin M, Hammel J, Hazen SL, Dweik RA. Sensitive cardiac troponin I predicts poor outcomes in pulmonary arterial hypertension. Eur Respir J 2012;39:939-44.
43. Salim A, Hadjizacharia P, Brown C, Inaba K, Teixeira PG, Chan L et al. Significance of troponin elevation after severe traumatic brain injury. J Trauma 2008;64:46-52.